Chengdu Shengnuo Biopharm is a company operating in the pharmaceutical industry.
Chengdu Shengnuo is one of the leading peptide manufacturers in China. There are 5 US-DMF of Peptide APIs: Liraglutide, Bivalirudin, Eptifibatide, Icatibant and Octreotide. The below US-DMFs will be submitted soon: Linaclotide, Degarelix, Teriparatide,Ziconotide,Exenatide and Ganirelix soon. Shengnuo also have a few Chinese GMP APIs: Atosiban,Carbetocin, Octreotide, Enfuvirtide,Thymalfasin, Somatostatin, Thymopentin and Levosimendan.
Company type
Products and services
Biopharmaceuticals, APIs (Active Pharmaceutical Ingredients)
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Address
Chengdu Shengnuo Biopharm, Section 1, Gongye Avenue, Dayi County, Chengdu, Sichuan, China, 611330
